Viewing affirmative mentions of gene expression of IL2 (H. sapiens) in kidney

Full-text article links are indicated by after the article reference.

Document Target Regulator Anatomy Sentence
Yoshimura and Kahan (1985)interleukin-2kidneyPharmacodynamic assessment of the in vivo cyclosporine effect on interleukin-2 production by lymphocytes in kidney transplant recipients.
Winandy et al. (1998)IL-2 genekidneyA comparison was made using serial dilutions of recombinant human IL-2, limiting dilutions of baby hamster kidney (BHK) cells transfected with human IL-2 gene and in the context of clinical tests performed for the detection of pre-transplant HTLp.
Schanz et al. (1994)IL-2kidneyLymphocytes from healthy individuals as well as from patients with end stage kidney disease and no previous allosensitization exhibited a relative radioresistance of their IL-2 production up to gamma irradiation doses of 40-60 Gy.
Conradt et al. (1989)interleukin-2kidneyExpression of human interleukin-2 in recombinant baby hamster kidney, Ltk-, and Chinese hamster ovary cells.
Morgun et al. (2003)IL-2kidneyThe finding of the association of T/T but not T/G genotype with acute kidney rejection was unexpected considering that both genotypes were shown to be associated with equal (low) IL-2 in vitro production.
Härtel et al. (2004)IL-2 mRNAkidneyWe also quantified IL-2 mRNA expression in patients undergoing tacrolimus (n = 4) or cyclosporin A (CsA; n = 4) monotherapy before ex vivo living-donor kidney transplantation.
Härtel et al. (2004)IL-2 mRNAkidneyKinetic profiles of IL-2 mRNA expression also revealed individually distinct degrees of calcineurin inhibitor sensitivity in patients undergoing tacrolimus or CsA monotherapy before living-donor kidney transplantation.
Vie et al. (1985)interleukin IIkidneyIncreased interleukin II production during kidney allograft rejection.
Severini et al. (1996)interleukin-2kidneyThe influence of uremic middle molecules on in vitro lymphocyte blast transformation and interleukin-2 production was studied in 12 patients on long-term hemodialysis and 12 healthy control subjects with normal kidney function.
Chabannes et al. (1988)IL-2kidneyThe effect of CsA on antigen-induced IL-2 receptor expression was studied on a human T lymphocyte clone (4AS) obtained from cells infiltrating a rejected human kidney.
Amato et al. (2007)IL-2kidneyWe provided novel structural and functional information on the expression of the IL-2 receptor in kidney cancer cells and in other normal and neoplastic human epithelial tissues.
Gluckman et al. (1983)Interleukin-2kidneyInterleukin-2 production after blood transfusions in prospective kidney transplant recipients.
Grimm et al. (1995)interleukin-2kidneyThe proportion of kidney biopsies expressing detectable message for interleukin-2 (IL-2), interleukin-4 (IL-4), and interferon-gamma (IFN-gamma) by in situ hybridization were similar to those reported using RT-PCR.
Conradt et al. (1989)IL-2kidneyOnly the NeuAc alpha 2-3Gal beta 1-3[NeuAc alpha 2-6]GalNAc oligosaccharide structure or the NeuAc alpha 2-3Gal beta 1-3GalNAc were found in all IL-2 preparations secreted from recombinant Ltk-, Chinese hamster ovary, and baby hamster kidney cell lines.
Soulillou and Jacques (1989)IL2kidneyAntibodies directed against light chain (P55) of interleukin 2 (IL2) receptor and able to interfere with IL2 binding on the IL2-receptor in its high-affinity conformation (only expressed on activated T cells) are effective in various animal models and recently in a preventive protocol in human kidney graft recipients.
McLean et al. (1997)IL-2kidneyIL-2 and gamma-interferon gene expression are necessary, but not sufficient, for the development of acute cellular rejection in the first 10 days of kidney transplantation, and are more closely associated with the period leading up to rejection than with the period of graft dysfunction.
Quan and Quan (2003)IL-2kidneyIL-2 at this outpatient dose and schedule is well tolerated and displays some evidence of activity in melanoma and kidney cancer.
Escudier et al. (1995)interleukin 2kidney[Treatment of metastatic kidney neoplasms with a new interleukin 2 protocol: The experience of the Gustave-Roussy Institute].
Muluk et al. (1991)IL-2kidneyIn the present study, we measured alloantigen-stimulated IL-2 production by PBL from 42 kidney transplant recipients to characterize the strength of the three T helper-APC pathways.
Négrier and Philip (1993)interleukin 2kidney[Has interleukin 2 modified the outcome of metastatic kidney cancer?].
Härtel et al. (2002)IL-2kidneyMETHODS: We used a human whole blood assay to determine basal (unstimulated) IL-2, IL-4, and tumor necrosis factor-alpha (TNF-alpha) mRNA concentrations and expression kinetics after anti-CD3/anti-CD28 monoclonal antibody costimulation in kidney transplant recipients undergoing CsA-based immunosuppressive triple therapy and in healthy controls (ex vivo study I).
Teixeira et al. (2009)IL2KidneyAll studies were conducted using a recombinant Baby Hamster Kidney (BHK) cell line expressing a fusion glycoprotein IgG1-IL2 cultured in batch and fed-batch modes.
Górski and Or?owski (1978)lymphokinekidneyLikewise, cells from patients with kidney allografts obtained during an uneventful postoperative course did not influence lymphokine synthesis.
Ohnishi et al. (1989)IL-2kidneyThe gel filtration profile of 125I-IL-2 in the serum specimens remained the same as that of the originally injected sample, and differed completely from that in the urine specimens, suggesting that 125I-IL-2 was metabolized in the kidney.
Weiler et al. (1998)IL-2kidneyIn rejected human kidney allografts, elevated IL-15, but not IL-2, mRNA is expressed, suggesting a role for IL-15 in the rejection process.
Maffezzini et al. (1994)IL-2kidney[Immunotherapy with subcutaneous recombinant IL-2 and interferon combined with surgery in advanced stage carcinoma of the kidney].
Savin et al. (1993)IL-2kidneySpontaneous blastogenesis profiles and IL-2 receptor expression on kidney allograft.
Böhler et al. (2009)IL-2kidneyAge was positively correlated with TNF-alpha expression in all three patient populations, and with IL-2 expression in healthy volunteers and kidney-transplant patients.
Hesse et al. (2003)interleukin-2kidneyThe applicability of a protein-free medium for the production of recombinant human interleukin-2 with baby hamster kidney cells in airlift bioreactors was investigated.
Grassi et al. (2006)interleukin-2kidneyPatients who undergo a renal transplant also require a pharmacological immunosuppressor therapy with cyclosporine (CsA) as well as anti-hypertensive calcium channel-blockers (CCBs); the former suppresses interferon and interleukin-2 production thus interfering with T cell cell-mediated activity, while the latter are used in order to counteract the nephrotoxicity of CsA which causes the local release, of thromboxane A2 with vascular vasoconstriction in the kidney.
Donskov et al. (2004)IL-2kidneyCore needle biopsies of metastatic and/or the primary kidney cancer were obtained before interleukin-2 (IL-2)- and IFN-alpha-based immunotherapy in 34 patients and repeated after 5 weeks in 25 patients.
Kaminska et al. (2007)IL-2kidneyRESULTS: Compared with normal kidney tissue from living donor, high gene expression of IFN-gamma, TGF-beta1, PDGF-B, IL-2, IL-6, and IL-10 was detected in all procurement specimens.
Kami?rska et al. (2006)IL-2kidney[Gene expression of INF-gamma, IL-10, IL-2, IL-6, PDGF-B i TGF-beta in kidney tissue after renal transplantation].
Essa et al. (2002)IL-2kidneyThe levels of Th2-type cytokines (interleukin (IL-) 4 and IL-10) in AA-negative and AA-positive kidney transplant recipients were similar but the levels of the Th1-type cytokines interferon-gamma, tumor necrosis factor-alpha (P<0.05) and IL-2 were significantly lower in AA-positive kidney transplant recipients (P<0.0005).
Pawlik et al. (2008)IL-2kidneyThe aim of the study was to evaluate the promoter polymorphism of TNF-alpha gene (-308 promoter polymorphism), IL-2 gene (-330 promoter polymorphism), IL-4 gene (-590 promoter polymorphism), and IL-6 gene (-174 promoter polymorphism) in renal transplant recipients with allograft duration under and over 10 years to establish whether aforementioned polymorphism are involved in kidney allograft survival.
Abramowicz et al. (1989)interleukin-2kidneyHigh levels of tumor necrosis factor-alpha, interleukin-2, and gamma-interferon appeared in the circulation of kidney transplant recipients after the first injection of the monoclonal antibody OKT3.
Li et al. (2008)IL-2kidneyThe levels of IFN-gamma, IL-2, and TNF-alpha were increased in the spleen, kidney, and heart throughout the study period.